MAZZEI, TERESITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.794
EU - Europa 10.139
AS - Asia 7.031
SA - Sud America 1.157
OC - Oceania 216
AF - Africa 138
Continente sconosciuto - Info sul continente non disponibili 5
Totale 33.480
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.660
RU - Federazione Russa 4.114
SG - Singapore 2.082
CN - Cina 1.690
PL - Polonia 1.556
HK - Hong Kong 1.317
IE - Irlanda 1.103
BR - Brasile 940
IT - Italia 890
KR - Corea 889
SE - Svezia 835
DE - Germania 465
UA - Ucraina 377
VN - Vietnam 319
FI - Finlandia 308
IN - India 257
AU - Australia 206
GB - Regno Unito 197
TR - Turchia 116
JO - Giordania 106
FR - Francia 97
AR - Argentina 86
CA - Canada 66
CI - Costa d'Avorio 45
ID - Indonesia 45
ES - Italia 44
MX - Messico 39
JP - Giappone 37
CH - Svizzera 34
EC - Ecuador 33
BD - Bangladesh 32
ZA - Sudafrica 30
IQ - Iraq 28
NL - Olanda 28
BE - Belgio 26
CO - Colombia 24
PE - Perù 22
VE - Venezuela 18
MA - Marocco 16
SC - Seychelles 16
PY - Paraguay 13
SA - Arabia Saudita 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 12
CL - Cile 12
NZ - Nuova Zelanda 10
PK - Pakistan 9
AZ - Azerbaigian 8
CZ - Repubblica Ceca 8
IR - Iran 8
AT - Austria 7
BJ - Benin 7
LT - Lituania 7
UY - Uruguay 7
AL - Albania 6
JM - Giamaica 6
TW - Taiwan 6
EG - Egitto 5
GR - Grecia 5
KZ - Kazakistan 5
LB - Libano 5
OM - Oman 5
TN - Tunisia 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
HN - Honduras 4
LU - Lussemburgo 4
MK - Macedonia 4
PH - Filippine 4
BG - Bulgaria 3
DK - Danimarca 3
EU - Europa 3
NP - Nepal 3
PS - Palestinian Territory 3
PT - Portogallo 3
TH - Thailandia 3
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
EE - Estonia 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
KW - Kuwait 2
LY - Libia 2
MY - Malesia 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
AO - Angola 1
AP - ???statistics.table.value.countryCode.AP??? 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
DM - Dominica 1
ET - Etiopia 1
GT - Guatemala 1
Totale 33.462
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.876
Warsaw 1.552
Singapore 1.340
Chandler 1.148
Dublin 1.100
Hong Kong 1.051
Fairfield 1.038
Ashburn 932
Seoul 861
Jacksonville 678
Hefei 608
Woodbridge 480
Cambridge 465
Seattle 422
Houston 381
Wilmington 374
Beijing 319
Buffalo 295
Princeton 259
Ann Arbor 226
Los Angeles 221
Melbourne 202
Boston 193
Boardman 177
Mumbai 163
Lawrence 151
Altamura 136
Florence 129
The Dalles 121
Ho Chi Minh City 116
Dallas 114
Moscow 112
Medford 106
Munich 95
Shanghai 93
São Paulo 78
Kent 76
New York 75
San Diego 63
Hanoi 62
Milan 58
Izmir 55
Norwalk 51
Dearborn 46
Redondo Beach 46
Turku 46
Abidjan 45
Paris 42
West Jordan 41
Helsinki 39
Hillsboro 38
Falls Church 36
Tokyo 36
Clifton 35
Rome 35
Bremen 32
San Jose 31
Toronto 31
Rio de Janeiro 30
Bern 28
Bengaluru 26
Guangzhou 26
Auburn Hills 22
Brooklyn 22
Phoenix 22
Pune 22
Yubileyny 22
Belo Horizonte 21
Brussels 21
London 21
Andover 19
Jakarta 19
Dong Ket 18
Tianjin 18
Bologna 17
Denver 16
Frankfurt Am Main 16
Haiphong 16
Redwood City 16
Da Nang 15
Montreal 15
Brasília 14
Buenos Aires 14
Chennai 14
Frankfurt am Main 14
Johannesburg 14
Stockholm 14
Curitiba 13
Lima 13
Porto Alegre 13
Barcelona 12
Catania 12
Guarulhos 12
Guayaquil 12
Tashkent 12
Manaus 11
Palermo 11
Poplar 11
Bari 10
Dhaka 10
Totale 21.335
Salva come PNG Salva come JPEG
Nome #
Cytotoxic activity of 3-nitropyrazolo[5,1-c][1,2,4]benzotriazine derivatives: a new series of anti-proliferative agents. 324
Farmaci antineoplastici - Farmaci inibitori della trasduzione del segnale - Farmaci inibitori di protein chinasi 303
Thymidylate synthase expression and genotype have no major impact on the clinical outcome of colorectal cancer patients treated with 5-fluorouracil 293
A survey on infection management practices in Italian ICUs 291
How to manage aspergillosis in non-neutropenic intensive care unit patients. 278
A survey on infection management practices in Italian ICUs. 270
Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic Acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy. 261
Intraoperative positive fluid balance improves tissue diffusion of ceftizoxime. 255
Treatment of extensively drug-resistant Gram-negative infections in critically ill patients: Outcome of a consensus meeting at the 13th Asia-Pacific Congress of Clinical Microbiology and Infection, October 2012 255
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 247
Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: Where are we now? 244
Breakthrough Cancer Pain: Preliminary Data of The Italian Oncologic Pain Multisetting Multicentric Survey (IOPS-MS) 230
Vancomycin in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: End of an era? 213
Comportamenti sessuali e contraccezione 208
Marked variation of thymidylate synthase and folylpolyglutamate synthetase gene expression in human colorectal tumors. 201
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 196
Cellular pharmacology of gemcitabine. 188
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 183
MOLECULAR CHARACTERIZATION OF ESTABLISHED HUMAN COLON CARCINOMA CELL LINES (HCT-8) MADE RESISTANT TO 5-FLUOROURACIL BY DIFFERENT SELECTION SCHEDULES 181
Stable disease in a patient with metastatic leiomyosarcoma treated with trabectedin 181
Cytotoxicity and DNA binding properties of a chloro glycylhistidinate gold(III) complex (GHAu). 180
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors 171
Gender-related health in tuscany 171
D13Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 168
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 163
Ertapenem peritoneal fluid concentrations in adult surgical patients. 161
Azithromycin concentrations in serum and bronchial secretions of patients with cystic fibrosis 160
Conclusions. Role of the oral Beta-lactams in the treatment of exacerbations of chronic bronchitis: critical analysis and therapeutics recommendations 159
Chromosomal characterization of methotrexate-resistant human T-lymphoblast leukemia cells (CCRF-CEM) with impaired polyglutamylation. 157
Amoxicillin/clavulanic acid versus cefotaxime for antimicrobial prophylaxis in abdominal surgery: a randomized trial. 156
Cytotoxicity, DNA damage, and cell cycle perturbations induced by two representative gold(III) complexes in human leukemic cells with different cisplatin sensitivity 156
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 156
Retrospective analysis of 77 patients with ovarian cancer undergoing genetic testing for BRCA1 and BRCA2 mutations 155
Differential inhibitory effects on human endometrial carcinoma cell growth of luteinizing hormone-releasing hormone analogues. 152
Increased levels of CA 125 and CA 19·9 serum tumour markers following cyclic combined hormone replacement therapy 151
Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression 151
5-methyltetrahydrofolate (mTHF) induces monocytes differentiation in HL60 cells 148
Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin 148
Adverse effects of macrolide antibacterials. 146
Adverse drug reactions in oncoLogy: intEnsive monitoring program on drug toXicity of biotechnological medicatioNs anD taRget therapies in Oncologic patientS - the ALEXANDROS observational study 145
Gold(III) Complexes with Bipyridyl Ligands: Solution Chemistry, Cytotoxicity and DNA Binding Properties 145
The most appropriate therapeutic strategy for acute lower respiratory tract infections: a Delphi-based approach. 144
In vivo pharmacodynamic evaluation of clarithromycin in comparison to erythromycin. 144
Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer 143
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 141
Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options 141
Marked variation thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression in human colorectal cancer 139
Concentration of moxifloxacin in plasma and tonsillar tissue after multiple administration in adult patients. 139
Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum 139
Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds. 138
Quantitative analysis by polymerase chain reaction (PCR) of genes involved in resistance to cytotoxic antimetabolites 137
Betalactam therapy and intestinal flora. 137
Induction of differentiation of HL-60 cells along the monocytic pathway by 5-methyltetrahydrofolate. 137
Pharmacokinetics and endocrine effects of leuprolide depot in advanced prostatic cancer: a dose-response analysis 136
5-methyltetrahydrofolate (MeTHF) enhances fluoropyrimidine cytotoxicity against human leukemia cells in vitro 135
Evaluation of methotrexate (MTX) sensitivity by an ATP bioluminescence assay in human leukemia cells 135
ADVANCED COLORECTAL CANCER (ACRC) IN ELDERLY PATIENTS: EVALUATION OF THREE DIFFERENT OXALIPLATIN-BASED CHEMOTHERAPY REGIMENS - Session D: Colo-rectal Cancer 135
Pharmacokinetic and pharmacodynamic aspects of antimicrobial agents for the treatment of uncomplicated urinary tract infections. 135
The penetration of intramuscular cefotetan disodium into human extravascular fluid and maternal milk secretion. 134
Therapeutic recommendations of the multidisciplinary group. 134
Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against staphylococci and streptococci. 134
Identification of pharmacogenomic markers of 5-fluorouracil-based chemotherapy in colorectal cancer 134
Antimicrobial prophylaxis in prosthetic joint implant surgery: a comparative multicenter trial between teicoplanin and cefazolin 133
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil (5-FU) and l-folinic acid (l-LV) alone or combined with levamisole (LEV) or interferon alpha2a (IFN alpha2a). Preliminary toxicological results of a multicenter study of the Gruppo Oncologico-Chirurgico Cooperativo Italiano (GOCCI) 133
Pharmacokinetics, endocrine and antitumour effects of leuprolide depot (TAP-144-SR) in advanced prostatic cancer: a dose-response evaluation. 133
Comparative pharmacokinetic evaluation of ceftriaxone and cefotaxime in coincidence for short-term antimicrobial prophylaxis in surgery 133
Analisi cariologica di linee cellulari leucemiche umane CCRF-CEM resistenti al metotressato (MTX) per alterata poliglutammilazione. 131
Phase I clinical trial of a new alkylating agent, PTT-119 130
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphisms in primary colorectal cancer patients 130
Antimicrobial chemoimmunoprophylaxis in colorectal surgery with cefotetan and thymostimulin: prospective, controlled multicenter study. Italian Study Group on Antimicrobial Prophylaxis in Abdominal Surgery. 130
Pharmacokinetics of melphalan (L-PAM) during hyperthermic perfusion in patients with melanoma of the limbs 129
Pharmacokinetic evaluation of meropenem and imipenem in critically-ill patients with sepsis. 129
Correlation between thymidylate synthase (TS) mRNA expression and TS gene promoter polymorphysms in primary colorectal cancer patients. 128
Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: a review. 127
Intra-arterial chemotherapy with 5-fluorouracil and 5-methyltetrahydrofolate in the treatment of unresectable liver metastases from colorectal cancer 127
Quantitation of intratumoral thymidylate synthase (TS) and folylpolyglutamate synthetase (FPGS) gene expression by the Polymerase Chain Reaction (PCR): marked variation among human colorectal cancer patients 126
Enhancement of fluoropyrimidine cytotoxicity by 5-methyltetrahydrofolate in a human leukemia cell line, CCRF-CEM. 126
Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusion. 126
Pharmacokinetics of oral medroxyprogesterone acetate at moderate doses. 125
Phase I trial of a novel alkylating agent 125
Pharmacological rationale for antibiotic treatment of intra-abdominal infections. 125
PHASE II TRIAL OF 5-FLUOROURACIL AND THE NATURAL L-ISOMER OF FOLINIC ACID IN THE TREATMENT OF ADVANCED COLORECTAL CARCINOMA. 124
Biochemical modulation of fluoropyrimidines by antifolates and folates in an in vitro model of human leukemia. 124
Adjuvant therapy of colorectal carcinoma with 5-fluorouracil and l-folinic acid alone or combined with levamisole or interferon-alfa2a. Preliminary toxicological results of a multicenter study of the Italian Cooperative Oncological-Surgical Group (GOCCI) 124
[Plasma and tissue antibiotic concentrations: what is their prognostic value?] 123
Cefodizime in skin suction blister fluid and serum following a single intravenous or intramuscular dose in adult patients. 123
Pharmacokinetics of dirithromycin in patients with mild or moderate cirrhosis 123
The pharmacokinetics and pharmacodynamics of the carbapenems: focus on doripenem 123
In vitro postantibiotic effect and postantibiotic leukocyte enhancement of tobramycin. 122
Leuprorelin acetate depot in advanced prostatic cancer: a phase II multicentre trial. 122
Mechanisms of methotrexate (MTX) resistance in human colon carcinoma cells DLD-1 121
Preliminary results of a phase II multicenter study on the clinical efficacy and safety to the LH-RH analog leuprolide in the treatment of prostatic carcinoma 121
Efficacy of caspofungin against Aspergillus terreus. 121
Modulation of dihydrofolate reductase gene expression in methotrexate-resistant human leukemia CCRF-CEM/E cells by antisense oligonucleotides. 121
Etiology issues and problems of antibiotic resistance 121
Dibekacin in vitro activity on recently isolated bacterial strains from various clinical materials. 120
Efficacy of 3-(p-fluorofenyl)-L-alanyl-3-m-bis(2-chloroethyl)amino-phenyl-L-methionine ethoxy HCl (PTT-119) on human leukemia cell lines 120
Amikacin in obstetric, gynecologic, and neonatal infections: laboratory and clinical studies. 120
Pharmacological aspects of the antibiotics used for urological diagnostic procedures 120
Pharmacokinetics and blister fluid penetration of ticarcillin/clavulanate in adults 119
Totale 15.750
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.775
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.775
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.238 0 0 0 0 0 285 60 199 148 260 113 173
2021/20221.481 33 212 45 95 45 45 47 110 58 34 315 442
2022/20234.514 404 491 145 426 465 919 618 279 516 27 128 96
2023/20241.648 98 187 346 84 117 235 67 337 21 63 42 51
2024/202511.429 471 1.226 679 1.694 3.212 1.601 167 550 650 244 443 492
2025/20266.958 1.401 1.940 1.257 1.117 1.184 59 0 0 0 0 0 0
Totale 33.682